Anti-CXCR7 antibody (bs-4897R)

Anti-CXCR7 antibody

DATASHEET

Host:Rabbit

Target Protein:CXCR7

IR:Immunogen Range:151-250/362

Clonality:Polyclonal

Isotype:IgG

Entrez Gene:57007

Swiss Prot:P25106

Source:KLH conjugated synthetic peptide derived from human CXCR7/RDC1:151-250/362 

Purification:affinity purified by Protein A

Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

Background:This gene encodes a member of the G-protein coupled receptor family. Although this protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP), it is now considered to be an orphan receptor, in that its endogenous ligand has not been identified. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. GCPR RDC1 is reported to be expressed in human cell lines and in cultured vascular endothelial cells and in rodent brain, kidney, lung, heart, spleen, pancreas, small intestine, blood, colon, and blood vessels. ESTs have been isolated from human normal bone marrow, brain, breast, cartilage, embryo, eye, fetal lung/testis/B-cell, heart, heart/melanocyte/uterus, kidney, liver/spleen, nerve, placenta, and umbilical libraries as well as several human cancer libraries.

Size:100ul

Concentration:1mg/ml

Applications:ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
ICC(1:100-500)
IF(1:100-500)

Cross Reactive Species:Human
Mouse
Rat
Dog
Pig
Cow
Horse
Rabbit
.

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Tissue/cell: rat brain tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
Incubation: Anti-CXCR7/RDC1 Polyclonal Antibody, Unconjugated(bs-4897R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining